Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review
about
The relationship between COPD and lung cancerThe Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis.Incidence and risk of infections associated with EGFR-TKIs in advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.Rhizoma Paridis Saponins Induces Cell Cycle Arrest and Apoptosis in Non-Small Cell Lung Carcinoma A549 Cells.Litchi seed extract inhibits epidermal growth factor receptor signaling and growth of Two Non-small cell lung carcinoma cellsMutational profiling of colorectal cancers with microsatellite instability.The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung Cancer.Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications.Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China.Anti-Metastatic Effect of Dehydrocorydaline on H1299 Non-Small Cell Lung Carcinoma Cells via Inhibition of Matrix Metalloproteinases and B Cell Lymphoma 2.Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer.miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma.Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.Precision medicine informatics.Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non-small cell lung cancer: A network meta-analysis.Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors.Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysis.Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.miR-373-3p promotes lung adenocarcinoma cell proliferation via APP.18F-Labeled Pyrido[3,4-d]pyrimidine as an Effective Probe for Imaging of L858R Mutant Epidermal Growth Factor Receptor.Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.The Efficacy and Toxicity of Gefitinib in Treating Non-small Cell Lung Cancer: A Meta-analysis of 19 Randomized Clinical Trials.
P2860
Q26781337-43FBB897-373F-4F5F-9335-5EBC5CEF6955Q30402360-62C120E2-C685-49EF-A3A4-7F4EBD8A8526Q33662730-765163ED-79A6-4E26-919B-F50AF77B06A4Q33710146-4AFB2451-78AB-4F3B-85F6-BACA6481DC2BQ36015618-B0273F39-5E66-4D09-9F10-01E030D6041BQ36241312-4876BF1E-F30A-4CE6-B607-8EC0BC17C2ACQ36561768-0C971BE3-F4F0-4D79-A77D-345ACC75F291Q37026204-9DE4381E-1C1E-4577-A7DD-97BDE8A95910Q37432540-72FC3DED-90C6-4B47-9407-F29D1D74094AQ37706099-F1A085BD-35AC-44C6-B64D-1524711F2982Q38718515-DC0FBC24-FA30-41A1-AFD5-B7A2D28A37F4Q38801383-87B801E1-094C-447D-9908-D2CA81B54446Q38820622-274DD1E9-95D4-42DC-90C9-2182F68E6F47Q40002473-F0E1485C-B3B4-4AF4-B992-4460B7247FA1Q42507839-A677EF15-7EF5-46E0-A7BB-E2AA30956267Q44536647-40ECAA9A-D7CC-42C5-81FC-EAF0048E0CECQ46108334-5D4A6560-5F67-4ACB-BDAD-DAEBBAE4E9AFQ47558369-784292BA-1421-4892-A145-7C41CA50B027Q47631458-D6121A12-BB3B-4763-8912-7DA3EA5F81ABQ50161575-0FF1C0E1-2455-4116-8AE7-C761A455860BQ53742828-EFBB5C53-FED0-4076-ACC1-9ACBF63AF978Q55281801-2DAA156C-F208-4DC7-BB0D-FEFDCD34907AQ55409671-AF381711-EC27-44C5-B013-969467CD30FB
P2860
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Use of the epidermal growth fa ...... ng cancer: a systematic review
@ast
Use of the epidermal growth fa ...... ng cancer: a systematic review
@en
Use of the epidermal growth fa ...... ng cancer: a systematic review
@nl
type
label
Use of the epidermal growth fa ...... ng cancer: a systematic review
@ast
Use of the epidermal growth fa ...... ng cancer: a systematic review
@en
Use of the epidermal growth fa ...... ng cancer: a systematic review
@nl
prefLabel
Use of the epidermal growth fa ...... ng cancer: a systematic review
@ast
Use of the epidermal growth fa ...... ng cancer: a systematic review
@en
Use of the epidermal growth fa ...... ng cancer: a systematic review
@nl
P2093
P2860
P356
P1433
P1476
Use of the epidermal growth fa ...... ng cancer: a systematic review
@en
P2093
P2860
P304
P356
10.3747/CO.22.2566
P407
P577
2015-06-01T00:00:00Z